ArticleEye (London, England)2011

Prognostic factors for visual outcomes 2-years after intravitreal bevacizumab for myopic choroidal neovascularization.

H Nakanishi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.